Abstract:Background: Cognitive deficits are present and familial in psychotic disorders and understanding the genetic contributors to these impairments in patients as well as healthy controls can contribute to our understanding of disease pathophysiology and its behavioral consequences. Methods: The Brief Assessment of Cognition in Schizophrenia (BACS) was administered to 1059 participants (schizophrenia N = 299, schizoaffective disorder N = 179, psychotic bipolar disorder N = 236, and controls N = 345). Participants were 15–65 years of age, clinically stable outpatients, and without significant neurological disorder, recent substance abuse, or dependence. Genotyping was performed using the Illumina PsychChip followed by imputation using the 1000 Genomes reference panel resulting in ~4.3 million SNP markers. The primary analysis was a mixed modeling GWAS approach (EMMAX) performed using BACS composite Z scores examined as a quantitative trait phenotype while controlling for genetically-driven ancestry measures, age, and sex. A secondary analysis additionally controlled for COMT Val158Met (rs4680) allele dosage which is a significant driver of cortical dopamine (DA) disposition. Probands and controls were grouped together and then also stratified by the top 2 genetically-derived ancestry groups. Results: The most prominent region associated with BACS performance across all participants was the SFMBT1 locus on Chr3 (lowest P = 1.110E-7; N = 18 SNPs P < 1.0E-5). Robust associations with the noncoding RNA LCO101928516 locus on chromosome 6 (lowest P = 4.1 × 10E-8; N = 14 SNPs P < 1 × 10E-5) were identified in participants of African ancestry. Additionally there were N = 30 genes or defined genetic loci harboring SNPs with suggestive (P < 1E-5) associations with BACS performance. Notable trends include genes previously associated with risk for schizophrenia or bipolar disorder (CDH12, DNM3, ITIH1, ITIH4, LRFN5, NMBR, NTRK3); brain structure, white matter, or development (INPP5D, LRFN5, NTRK3); and cognition (AKAP6, TNFSF10). After controlling for COMT Val158Met allele status, the microRNA gene (MIR44198b) on Chr12 revealed association trends (lowest P = 5.8 × 10E-8; N = 27 SNPs P < 1 × 10E-5) in those of African ancestry. Conclusion: The most prominent associations with performance across all participants were at the SFMBT1 locus related to histone and chromatin regulation. Other genes harboring suggestive findings include those previously associated with risk for psychotic disorders, brain structure or development, and cognition. When controlling for COMT Val158Met allele status, numerous SNPs in MIR44198b, which is known to target immunological regulators, revealed associations. These data suggest that cognitive impairments in psychotic disorders may be influenced by genes also known to be risk factors for psychiatric disorders, but also other genes related to brain processes, epigenetic gene regulation, or inflammation.

Genetic Analysis of Psychosis Biotypes: Shared Ancestry-Adjusted Polygenic Risk and Unique Genomic Associations

Psychosis Biotypes: Replication and Validation from the B-SNIP Consortium.

Differentiating Biomarker Features and Familial Characteristics of B-SNIP Psychosis Biotypes

GWAS OF BSNIP BIOFACTORS AND BIOTYPES AS INTERMEDIATE PHENOTYPES FOR PSYCHOSIS

Categorical and Dimensional Approaches for Psychiatric Classification and Treatment Targeting: Considerations from Psychosis Biotypes.

M94. Genetic Analyses of Cognitive Performance in Psychotic Disorders from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Consortium

Longitudinal Stability of Psychosis Biomarkers: Findings from the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP)

Supervised Machine Learning Classification of Psychosis Biotypes Based on Brain Structure: Findings from the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP).

A Polygenic Risk Score Analysis of Psychosis Endophenotypes Across Brain Functional, Structural, and Cognitive Domains.

A Genome-wide Association Analysis of a Broad Psychosis Phenotype Identifies Three Loci for Further Investigation

Intelligence As Proxy Phenotype Providing Insight into the Heterogeneity of Schizophrenia

M61. Data-Driven Approach Identified Functionally and Physiologically Distinct Psychosis Subtypes

Clinical Phenotypes Of Psychosis In The Bipolar-Schizophrenia Network On Intermediate Phenotypes (B-Snip)

Psychosis Endophenotypes: A Gene-Set-Specific Polygenic Risk Score Analysis.

White Matter Microstructure Across Brain-Based Biotypes for Psychosis - Findings from the Bipolar-Schizophrenia Network for Intermediate Phenotypes.

Association of neurotransmitter pathway polygenic risk with specific symptom profiles in psychosis

Polygenic Burden Analysis of Longitudinal Clusters of Psychopathological Features in A Cross-Diagnostic Group of Individuals with Severe Mental Illness

Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers

Novel Gene-Brain Structure Relationships in Psychotic Disorder Revealed Using Parallel Independent Component Analyses.

SU65. Neural Adaptation Differences among Psychosis Biotypes

Neurobiology-based Cognitive Biotypes Using Multi-scale Intrinsic Connectivity Networks in Psychotic Disorders